Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active Surveillance Post-Approval Atudy of the Stelkast Surpass Acetabular System

NCT01672086 is registered in ClinicalTrials.gov with StelKast, Inc. as lead sponsor.

NCT NCT01672086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01672086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active Surveillance Post-Approval Atudy of the Stelkast Surpass Acetabular System
Lead sponsor
StelKast, Inc.
Phase
Observational
Overall status
Terminated
Start date
August 31, 2012
Completion date
June 30, 2016
Enrollment
347 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

survivorship and long-term safety and effectiveness of the stelkast surpass acetabular system